We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 121-140 of 10,000 results
  1. Dexmedetomidine Regulates Autophagy via the AMPK/mTOR Pathway to Improve SH-SY5Y-APP Cell Damage Induced by High Glucose

    Neurodegenerative diseases and postoperative cognitive dysfunction involve the accumulation of β-amyloid peptide (Aβ). High glucose can inhibit...

    Pinzhong Chen, **aohui Chen, ... Ting Zheng in NeuroMolecular Medicine
    Article 05 April 2023
  2. Akt/mTOR Pathway Agonist SC79 Inhibits Autophagy and Apoptosis of Oligodendrocyte Precursor Cells Associated with Neonatal White Matter Dysplasia

    White matter dysplasia (WMD) in preterm infants due to intrauterine inflammation is caused by excessive apoptosis of oligodendrocyte precursor cells...

    Zhongni Li, Feng Zhang, ... Liqun Lu in Neurochemical Research
    Article Open access 28 November 2023
  3. Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe

    Background

    Renal cell carcinoma (RCC) was historically considered to be less responsive to radiation therapy (RT) compared to other cancer...

    Hari K. Rachamala, Vijay S. Madamsetty, ... Krishnendu Pal in Journal of Experimental & Clinical Cancer Research
    Article Open access 06 June 2024
  4. Activation of PI3k/Akt/mTOR Signaling Induces Deposition of p-tau to Promote Aluminum Neurotoxicity

    Aluminum neurotoxicity impairs learning and memory ability, but the molecular mechanism has not been elucidated. The aim of this study was to examine...

    Yirong Xu, Guangheng Zhang, ... Ye** Zhang in Neurotoxicity Research
    Article 06 September 2022
  5. IGF-1 Combined with OPN Promotes Neuronal Axon Growth in Vitro Through the IGF-1R/Akt/mTOR Signaling Pathway in Lipid Rafts

    This study aims to investigate the effect of insulin-like growth factor 1 (IGF-1) combined with osteopontin (OPN) on the protein expression levels...

    Qin Zhao, Hong Su, ... Botao Tan in Neurochemical Research
    Article 03 July 2023
  6. HDACs/mTOR inhibitor synergizes with pyrotinib in HER2-positive pancreatic cancer through degradation of mutant P53

    Background

    Pancreatic ductal adenocarcinoma (PDAC), as a highly lethal malignancy with high mortality, lacks of effective treatment. Canonical...

    Tiebo Mao, **aofei Zhang, ... Liwei Wang in Cancer Cell International
    Article Open access 01 December 2022
  7. Loss of RACK1 promotes glutamine addiction via activating AKT/mTOR/ASCT2 axis to facilitate tumor growth in gastric cancer

    Background

    Metabolic reprogramming is closely related to the development of gastric cancer (GC), which remains as the fourth leading cause of...

    Mengqian Chen, Gaojia Wang, ... Shushu Song in Cellular Oncology
    Article 14 August 2023
  8. CDCA5-EEF1A1 interaction promotes progression of clear cell renal cell carcinoma by regulating mTOR signaling

    Background

    Cell division cycle associated 5 (CDCA5) plays ontogenetic role in various human cancers. However, its specific function and regulatory...

    Xun Wang, An Shi, ... Jiwei Huang in Cancer Cell International
    Article Open access 24 April 2024
  9. Therapeutic silencing of mTOR by systemically administered siRNA-loaded neutral liposomal nanoparticles inhibits DMBA-induced mammary carcinogenesis

    Background

    Mammary carcinogenesis possesses great challenges due to the lack of effectiveness of the multiple therapeutic options available. Gene...

    Roja Sahu, Shivesh Jha, Shakti Prasad Pattanayak in British Journal of Cancer
    Article 19 October 2022
  10. Expression analysis of mTOR-associated lncRNAs in multiple sclerosis

    mTOR has been shown to be involved in the regulation of immune responses and differentiation of immune cells. This protein is a candidate molecule...

    Mohammadarian Akbari, Fatemeh Eshghyar, ... Soudeh Ghafouri-Fard in Metabolic Brain Disease
    Article 27 May 2022
  11. ROS/mtROS promotes TNTs formation via the PI3K/AKT/mTOR pathway to protect against mitochondrial damages in glial cells induced by engineered nanomaterials

    Background

    As the demand and application of engineered nanomaterials have increased, their potential toxicity to the central nervous system has drawn...

    **npei Lin, Wei Wang, ... Huangyuan Li in Particle and Fibre Toxicology
    Article Open access 15 January 2024
  12. Prognosticating Drug Targets and Responses by Analyzing Metastasis-Related Cancer Pathways

    Cancer is a chronologic disease characterized by abnormal cellular proliferation and the potential to spread to other parts of the body. Activating...
    Priya Joon, Monika Kadian, ... Milind Parle in Handbook of Oncobiology: From Basic to Clinical Sciences
    Reference work entry 2024
  13. Small biomarkers with massive impacts: PI3K/AKT/mTOR signalling and microRNA crosstalk regulate nasopharyngeal carcinoma

    Nasopharyngeal carcinoma (NPC) is one of the most common malignant tumours of the head and neck in Southeast Asia and southern China. The...

    Hai-Long LI, Nian-Hua Deng, ... Yue-Hua Li in Biomarker Research
    Article Open access 26 July 2022
  14. Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example

    Compared with those in adenocarcinoma, PIK3CA mutations are more common in squamous cell carcinoma (SCC), which arises from stratified squamous...

    Shutao Zheng, Shuo He, ... **aomei Lu in Molecular Biomedicine
    Article Open access 15 April 2024
  15. Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K/AKT/mTOR signal pathway

    Gastric cancer (GC) is the most common malignant tumor of digestive system. Bufalin extracted from Venenum Bufonis is one of the most effective...

    Guang Chen, Huhu Zhang, ... Lina Yang in Apoptosis
    Article 30 May 2023
  16. Knockdown of TFRC suppressed the progression of nasopharyngeal carcinoma by downregulating the PI3K/Akt/mTOR pathway

    Background

    The transferrin receptor (TfR) encoded by TFRC gene is the main cellular iron importer. TfR is highly expressed in many cancers and is...

    Guofei Feng, Yasushi Arima, ... Mariko Murata in Cancer Cell International
    Article Open access 29 August 2023
  17. Glial Activation, Mitochondrial Imbalance, and Akt/mTOR Signaling May Be Potential Mechanisms of Cognitive Impairment in Heart Failure Mice

    Heart failure (HF) is a major health burden worldwide, with approximately half of HF patients having a comorbid cognitive impairment (CI). However,...

    Yanan Wu, Kaiyi Zhou, ... Sheng Wang in Neurotoxicity Research
    Article 05 September 2023
  18. MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K/AKT/mTOR pathway

    Objective

    Previous studies have indicated that neurotransmitters play important roles in the occurrence and development of gastric cancer. MAOA is an...

    Yang-Yang Wang, Yao-Qi Zhou, ... Jun Li in Cellular Oncology
    Article 30 May 2023
  19. Ibrutinib Delays ALS Installation and Increases Survival of SOD1G93A Mice by Modulating PI3K/mTOR/Akt Signaling

    Amyotrophic lateral sclerosis (ALS) is a fatal multisystem degenerative disorder with minimal available therapeutic. However, some recent studies...

    Chengyou Zheng, Weifen Li, ... Shupeng Li in Journal of Neuroimmune Pharmacology
    Article 16 June 2023
  20. Morphine Induced Neuroprotection in Ischemic Stroke by Activating Autophagy Via mTOR-Independent Activation of the JNK1/2 Pathway

    Morphine (Mor) has exhibited efficacy in safeguarding neurons against ischemic injuries by simulating ischemic/hypoxic preconditioning (I/HPC)....

    Wenying Chi, Yaru Huang, ... Fanjun Meng in Neurochemical Research
    Article 05 June 2024
Did you find what you were looking for? Share feedback.